Natural product drug discovery and development: the United States National Cancer Institute role.
Cragg
Gordon M
GM
Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center, Fairview Center, Suite 206, P. O. Box B, Frederick, MD 21702-1201, USA.
D000818:Animals; D019380:Anti-HIV Agents / Q000302:isolation & purification; D000970:Antineoplastic Agents / Q000266:history / Q000302:isolation & purification* / Q000627:therapeutic use; D001685:Biological Factors / Q000266:history / Q000302:isolation & purification; D003299:Cooperative Behavior; D015195:Drug Design; D004341:Drug Evaluation / Q000191:economics / Q000379:methods; D004353:Drug Evaluation, Preclinical / Q000191:economics / Q000379:methods; D049673:History, 20th Century; D006801:Humans; D007391:International Cooperation; D009316:National Institutes of Health (U.S.) / Q000266:history; D009369:Neoplasms / Q000188:drug therapy; D010946:Plants, Medicinal / Q000737:chemistry; D014481:United States
D019380:Anti-HIV Agents; D000970:Antineoplastic Agents; D001685:Biological Factors